Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Effects of Morphine
NCT04342130Phase 4Completed
- Sponsor
- University of Rochester
- Start
- Apr 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of morphine in chronic low back pain (CLBP), sponsored by University of Rochester. Primary endpoints: Mean Change in Subcortical Brain Structure Volume at 1 hour, Change in Brain Response to Highly Caloric Drink at 1 hour and 1 more. Started Apr 2018; status: completed.
02
Drugs
morphine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT04342130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04342130.